Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

RHaemorrhagic Fever with Renal Syndrome Bivalent Purified Vaccine (Vero cell)

Approval Number

国药准字S20050109

Company兰州生物制品研究所有限责任公司

Registration Date

June 22, 2020

Drug Information

Generic Name

双价肾综合征出血热纯化疫苗(Vero细胞)

Dosage Form

注射剂

Strength

每瓶1.0ml。每1次人用剂量为1.0ml。

Drug Type

生物制品

Registration Date

June 22, 2020

Company Information

Applicant Company

Company Name兰州生物制品研究所有限责任公司

Manufacturing Company

Company Name兰州生物制品研究所有限责任公司

Company Address

兰州市城关区盐场路888号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy